Tango Therapeutics, Inc.
TNGX
$6.61
$0.111.69%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -145.57M | -132.26M | -130.30M | -123.40M | -116.49M |
| Total Depreciation and Amortization | 2.49M | 2.50M | 2.50M | 2.50M | 2.49M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 28.92M | 29.36M | 28.05M | 23.93M | 23.53M |
| Change in Net Operating Assets | -34.10M | -34.93M | -31.75M | -25.35M | -29.59M |
| Cash from Operations | -148.25M | -135.34M | -131.50M | -122.32M | -120.07M |
| Capital Expenditure | -914.00K | -610.00K | -754.00K | -856.00K | -757.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 132.92M | 128.54M | 86.88M | 68.77M | -20.56M |
| Cash from Investing | 132.01M | 127.93M | 86.13M | 67.92M | -21.32M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 3.95M | 4.68M | 47.66M | 48.40M | 126.28M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -241.00K | -241.00K |
| Cash from Financing | 3.95M | 4.68M | 47.66M | 48.16M | 126.04M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -12.29M | -2.73M | 2.29M | -6.24M | -15.34M |